Evidence map›Paper›PMID 41444324›Full record

ArticleScientific reports2025

Mechanistic insights into DEHP-induced progression of non-small cell lung cancer based on network toxicology and molecular docking.

Zhe Chen, Chi Wang, Yixing Li, Xiao Xiao, Heng Zhao, Bin He, Haotian Bai, Rui Zhao, Guangjian Zhang, Jinteng Feng

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhe ChenDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Chi WangZonglian College, Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Yixing LiDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Xiao XiaoDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Heng ZhaoDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Bin HeDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Haotian BaiDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Rui ZhaoDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China.
Guangjian ZhangDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China. michael8039@xjtu.edu.cn.
Jinteng FengDepartment of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, ShaanXi, P.R. China. fengjinteng@xjtu.edu.cn.

Funding

Key Research and Development Program of Shaanxi Province 2024SF-ZDCYL-02-09the Noncommunicable Chronic Diseases-National Science and Technology Major Project SQ2023AAA031457the Project of Traditional Chinese Medicine Administration of Shaanxi Province 2023-ZDYJSL-004
6 · The paper itself

Abstract

Di(2-ethylhexyl) phthalate (DEHP), a widely used plasticizer, has been implicated in various health risks, including tumorigenesis. Non-small cell lung cancer (NSCLC), accounting for over 80% of lung cancer cases, remains a leading cause of cancer-related mortality. This study employed network toxicology and molecular docking to explore the molecular mechanisms underlying DEHP's toxic effects on NSCLC. DEHP and NSCLC targets were retrieved from CTD, SwissTargetPrediction, and GeneCards, yielding 225 overlapping genes. Protein-protein interaction (PPI) network analysis identified five core targets: TP53, JUN, SRC, AKT1, and ESR1. Gene Ontology (GO) and KEGG pathway enrichment analyses revealed significant involvement of the PI3K/AKT signaling pathway and regulation of apoptotic signaling in DEHP-induced NSCLC pathogenesis. Molecular docking confirmed strong binding affinities between DEHP and the core targets, with binding energies ranging from - 4.611 to -7.535 kcal/mol. These findings suggest that DEHP promotes NSCLC progression, metastasis, and chemoresistance through PI3K/AKT signaling and apoptotic pathway dysregulation. This study provides mechanistic insights into DEHP's role in NSCLC and highlights the need for public health interventions to mitigate DEHP exposure. Further experimental validation is warranted to strengthen these findings and guide the development of targeted therapies.

Indexed as

Carcinoma, Non-Small-Cell LungDiethylhexyl PhthalateLung NeoplasmsMolecular Docking SimulationApoptosisDisease ProgressionHumansPhosphatidylinositol 3-KinasesProtein Interaction MapsProto-Oncogene Proteins c-aktSignal TransductionDiethylhexyl PhthalatePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktApoptosisDEHPMolecular dockingNetwork toxicologyNSCLCPI3K/AKT pathway

Identifiers

PMID41444324
PMCPMC12754051

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.